iPS PORTAL Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Investors
-
20
iPS PORTAL General Information
Description
Provider of research and development outsourcing services intended to support the practical application of induced pluripotent stem cell technology. The company's services include offering support for research, contract testing, development, and concept planning, and offering training programs in the field of cell culture to researchers, enabling healthcare companies to accelerate research and commercialization of drug discovery and regenerative medicine.
Contact Information
Website
www.ipsportal.comCorporate Office
- Louis Pasteur Medical Research Center Building
- 103-5 Tanakamonzen-cho, Sakyo-ku
- Kyoto, 606-8225
- Japan
Corporate Office
- Louis Pasteur Medical Research Center Building
- 103-5 Tanakamonzen-cho, Sakyo-ku
- Kyoto, 606-8225
- Japan
iPS PORTAL Timeline
iPS PORTAL Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 11-Mar-2026 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 23-Dec-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 30-Jun-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 08-Apr-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Mar-2015 | $831K | $12.7M | Completed | Generating Revenue | |
| 1. Seed Round | 09-Mar-2015 | $11.9M | $11.9M | Completed | Generating Revenue |
iPS PORTAL Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class B | ||||||||
| A Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
iPS PORTAL Patents
iPS PORTAL Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-WO2018158901-A1 | Cell analysis method and cell analysis apparatus | Active | 02-Mar-2017 | ||
| JP-6873390-B2 | Cell analysis method and cell analysis device | Active | 02-Mar-2017 | ||
| US-20200057294-A1 | Cell analysis method and cell analysis system | Active | 02-Mar-2017 | ||
| WO-2018158901-A1 | Cell analysis method and cell analysis system | Inactive | 02-Mar-2017 | ||
| US-11609537-B2 | Cell analysis method and cell analysis system using a holographic microscope | Active | 02-Mar-2017 | G03H1/0443 |
iPS PORTAL Signals
iPS PORTAL Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Exedy | Corporation | Minority | ||
| Kagawa Securities | Corporation | Minority | ||
| Kataoka Seisakusho | Corporation | Minority | ||
| NTT Data Group | Corporation | Minority | ||
| Kyoto | Government | Minority |
iPS PORTAL FAQs
-
When was iPS PORTAL founded?
iPS PORTAL was founded in 2014.
-
Where is iPS PORTAL headquartered?
iPS PORTAL is headquartered in Kyoto, Japan.
-
What is the size of iPS PORTAL?
iPS PORTAL has 20 total employees.
-
What industry is iPS PORTAL in?
iPS PORTAL’s primary industry is Biotechnology.
-
Is iPS PORTAL a private or public company?
iPS PORTAL is a Private company.
-
What is iPS PORTAL’s current revenue?
The current revenue for iPS PORTAL is .
-
How much funding has iPS PORTAL raised over time?
iPS PORTAL has raised $33.7M.
-
Who are iPS PORTAL’s investors?
Exedy, Kagawa Securities, Kataoka Seisakusho, NTT Data Group, and Kyoto are 5 of 20 investors who have invested in iPS PORTAL.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process